Combined Application of Cold Physical Plasma and Chemotherapeutics against Chondrosarcoma Cells
International Journal of Molecular Sciences · 25.06.2024 · 25 (13) · 6955
DOI: 10.3390/ijms25136955 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.06.2024. Verfasst von Andreas Nitsch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Str., 17475 Greifswald, Germ…. Hauptthemen laut MEDLINE: Chondrosarcoma, Plasma Gases, Cell Proliferation, Doxorubicin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, University Medicine Greifswald.
Abstract (Originalsprache)
Chondrosarcoma (CS) is a rare malignant bone sarcoma that primarily affects cartilage cells in the femur and pelvis. While most subtypes exhibit slow growth with a very good prognosis, some aggressive subtypes have a poorer overall survival. CS is known for its resistance to chemotherapy and radiotherapy, leaving surgery as the sole effective therapeutic option. Cold physical plasma (CPP) has been explored in vitro as a potential therapy, demonstrating positive anti-tumor effects on CS cells. This study investigated the synergistic effects of combining CPP with cytostatics on CS cells. The chemotherapeutic agents cisplatin, doxorubicin, and vincristine were applied to two CS cell lines (CAL-78 and SW1353). After determining their IC20 and IC50, they were combined with CPP in both cell lines to assess their impact on the cell proliferation, viability, metabolism, and apoptosis. This combined approach significantly reduced the cell proliferation and viability while increasing the apoptosis signals compared to cytostatic therapy alone. The combination of CPP and chemotherapeutic drugs shows promise in targeting chemoresistant CS cells, potentially improving the prognosis for patients in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Str., 17475 Greifswald, Germany.
- ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Straße 2, 17489 Greifswald, Germany.
- Clinic and Policlinic for Dermatology and Venerology, Rostock University Medical Center, Strempelstr. 13, 18057 Rostock, Germany.
- Department of General Pharmacology, Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, 17487 Greifswald, Germany.
ORCID-Profile: Andreas Nitsch, Sara Qarqash, Frank Schulze, Sander Bekeschus, Lyubomir Haralambiev
Förderung
- German Research Foundation
- University Medicine Greifswald
Zitieren
APA
Nitsch, A., Qarqash, S., Schulze, F., Nonnenmacher, L., Bekeschus, S., Tzvetkov, M. V., Wassilew, G. I., & Haralambiev, L. (2024). Combined Application of Cold Physical Plasma and Chemotherapeutics against Chondrosarcoma Cells. International Journal of Molecular Sciences, 25(13), 6955. https://doi.org/10.3390/ijms25136955
Vancouver
Nitsch A, Qarqash S, Schulze F, Nonnenmacher L, Bekeschus S, Tzvetkov MV, et al. Combined Application of Cold Physical Plasma and Chemotherapeutics against Chondrosarcoma Cells. International Journal of Molecular Sciences. 2024;25(13):6955. doi:10.3390/ijms25136955
BibTeX
@article{Nitsch2024,
author = {Nitsch, Andreas and Qarqash, Sara and Schulze, Frank and Nonnenmacher, Lars and Bekeschus, Sander and Tzvetkov, Mladen V and Wassilew, Georgi I and Haralambiev, Lyubomir},
title = {Combined Application of Cold Physical Plasma and Chemotherapeutics against Chondrosarcoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {6955},
doi = {10.3390/ijms25136955}
}
EUVIMED